RenovoRx, Inc.
RenovoRx, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Surgical & Medical Instruments & Apparatus.
The next scheduled catalyst is Next quarterly earnings (projected) on November 12, 2026, a projected date rather than a confirmed one. There are 2 upcoming events on record.
Cash runway is approximately 7.7 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.
| Date | Event | Type | Phase |
|---|---|---|---|
| November 12, 2026 est. | Next quarterly earnings (projected) | Earnings | — |
| June 15, 2027 | Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC | Trial Milestone | Phase 3 |
Track RNXT alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open RNXT in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| August 20, 2026 | 8-K filed: Other event | Filing | — |
| August 13, 2026 | Quarterly results filed (8-K) | Earnings | — |
| August 4, 2026 | 8-K filed: Other event | Filing | — |
| July 2, 2026 | 8-K filed: Listing / standard notice | Corporate | — |
| May 14, 2026 | Quarterly results filed (8-K) | Earnings | — |
| March 30, 2026 | Quarterly results filed (8-K) | Earnings | — |
| March 27, 2026 | 8-K filed: Leadership change | Corporate | — |
| March 23, 2026 | 8-K filed: Material agreement, Other event | Corporate | — |
| February 6, 2026 | 8-K filed: Leadership change, Other event | Corporate | — |
| January 2, 2026 | 8-K filed: Listing / standard notice | Corporate | — |
| November 14, 2025 | 8-K filed: Material agreement | Corporate | — |
| November 13, 2025 | Quarterly results filed (8-K) | Earnings | — |
| August 14, 2025 | Quarterly results filed (8-K) | Earnings | — |
| May 15, 2025 | Quarterly results filed (8-K) | Earnings | — |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.